Gregory David Casciaro
Director/Board Member bei KL ACQUISITION CORP
Profil
Gregory David Casciaro is currently the Chief Executive Officer at Foldax, Inc., an Independent Director at Colospan Ltd., and a Director at Yor Labs, Inc. He is also a Director at Tulavi Therapeutics, Inc., Cytokind, Inc., and an Independent Director at KL Acquisition Corp.
In the past, he served as President & Chief Executive Officer at General Surgical Innovations, Inc., President, Chief Executive Officer & Director at Cardiac Dimensions, Inc., Access Closure, Inc., Orquest, Inc., and Xtent, Inc. He was also a Director at Kerberos Proximal Solutions, Inc., Trireme Medical LLC, Apama Medical, Inc., AngioDynamics, Inc., and Dextera Surgical, Inc. Additionally, he served as an Independent Non-Executive Director at QT Vascular Ltd.
He started his career as a Manager-Area Sales at North American Instrument Corp.
and later became Vice President-Sales at Devices for Vascular Intervention, Inc. Casciaro received his undergraduate degree from Marquette University in 1982.
Aktive Positionen von Gregory David Casciaro
| Unternehmen | Position | Beginn |
|---|---|---|
| KL ACQUISITION CORP | Director/Board Member | 07.01.2021 |
Foldax, Inc.
 Foldax, Inc. Medical SpecialtiesHealth Technology Foldax, Inc. develops synthetic heart valves for delivering non-thrombogenic aortic and mitral valves. The company is headquartered in Salt Lake City, UT. | Chief Executive Officer | 18.10.2022 |
| Cytokind, Inc. | Director/Board Member | - |
Tulavi Therapeutics, Inc.
 Tulavi Therapeutics, Inc. BiotechnologyHealth Technology Tulavi Therapeutics, Inc. develops therapeutics to treat neurally mediated diseases. It helps to treat aberrant neural reflex arcs in peripheral and visceral diseases. The company was founded was founded by Corinne Bright, Fred Khosravi and Henry Chen and is headquartered in Mountain View, CA. | Director/Board Member | - |
Colospan Ltd.
 Colospan Ltd. Medical SpecialtiesHealth Technology Colospan Ltd. operates as a clinical stage and medical device company that develops a technology for colorectal surgery to prevent the profound clinical and economic pains associated with colorectal anastomotic leaks and diverting stomas. The company was founded by Boaz Assaf in December 2010 and is headquartered in Kfar Saba, Israel. | Director/Board Member | 05.10.2021 |
Yor Labs, Inc.
 Yor Labs, Inc. Medical SpecialtiesHealth Technology Yor Labs, Inc. offers an ultraportable-handheld device for diagnostic care. The company is headquartered in Portland, OR. | Director/Board Member | 25.10.2022 |
Ehemalige bekannte Positionen von Gregory David Casciaro
| Unternehmen | Position | Ende |
|---|---|---|
| QT VASC | Director/Board Member | 30.04.2021 |
Cardiac Dimensions, Inc.
 Cardiac Dimensions, Inc. Medical SpecialtiesHealth Technology Cardiac Dimensions, Inc. develops novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. It offers the CARILLON Mitral Contour System, a proprietary and implantable device designed to be positioned in the coronary sinus vein using cardiac catheterization techniques. The firm also offers patient enrollment, clinical testing, and medical consulting services. The company was founded by James W. Fitzsimmons and Scott Jordan Wolf in 2001 and is headquartered in Kirkland, WA. | Chief Executive Officer | 01.02.2020 |
| DEXTERA SURGICAL INC | Director/Board Member | 01.02.2018 |
| ░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Gregory David Casciaro
| Marquette University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ANGIODYNAMICS, INC. | Health Technology |
| Private Unternehmen | 18 |
|---|---|
| General Surgical Innovations, Inc. | Health Technology |
Kerberos Proximal Solutions, Inc.
 Kerberos Proximal Solutions, Inc. Electronic Equipment/InstrumentsElectronic Technology Kerberos Proximal Solutions, Inc. is a medical device company. It develops solutions to treat vascular disease. The company develops proximal embolic-protection technology to recover debris dislodged during angioplasty and stent placement Investors. Kerberos Proximal Solutions was founded in 2001 and is headquartered in Cupertino, CA | Electronic Technology |
Cardiac Dimensions, Inc.
Cardiac Dimensions, Inc. Medical SpecialtiesHealth Technology Cardiac Dimensions, Inc. develops novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. It offers the CARILLON Mitral Contour System, a proprietary and implantable device designed to be positioned in the coronary sinus vein using cardiac catheterization techniques. The firm also offers patient enrollment, clinical testing, and medical consulting services. The company was founded by James W. Fitzsimmons and Scott Jordan Wolf in 2001 and is headquartered in Kirkland, WA. | Health Technology |
Access Closure, Inc.
 Access Closure, Inc. Medical SpecialtiesHealth Technology Access Closure, Inc. manufactures and distributes medical devices for cardiovascular and peripheral vascular markets. Its products include Mynx ace, Mynx grip, Mynx sealant technology and flash ostial system. The company was in founded in 2002 by Farhad Khosravi and is headquartered in Santa Clara, CA. | Health Technology |
Xtent, Inc.
 Xtent, Inc. Medical SpecialtiesHealth Technology Xtent, Inc. is a medical devices manufacturing company. The company develops drug-eluting stent systems for the treatment of multi-vessel, multi-lesion coronary and peripheral vascular diseases. Xtent was founded in 2002 and is headquartered in Menlo Park, CA. | Health Technology |
Trireme Medical LLC
 Trireme Medical LLC Medical SpecialtiesHealth Technology Trireme Medical LLC develops and manufactures novel stent technology for the treatment of atherosclerotic disease. It offers coronary stent systems, balloon catheters, and percutaneous transluminal coronary angioplasty balloon catheters for the treatment of coronary and peripheral arterial disease. The company is focused on the United States and the emerging Asian markets. The company was founded by Eitan Konstantino and Feld Tanhum in 2005 and is headquartered in Pleasanton, CA, | Health Technology |
Apama Medical, Inc.
 Apama Medical, Inc. Medical SpecialtiesHealth Technology Apama Medical, Inc. operates as a medical device company which focuses on the treatment of atrial fibrillation. The firm focuses on the electrophysiology market and offers a vastly superior catheter-based solution for the fastest growing market segment, atrial fibrillation ablation. The company was founded by Amr Salahieh in 2009 and is headquartered in Campbell, CA. | Health Technology |
Foldax, Inc.
Foldax, Inc. Medical SpecialtiesHealth Technology Foldax, Inc. develops synthetic heart valves for delivering non-thrombogenic aortic and mitral valves. The company is headquartered in Salt Lake City, UT. | Health Technology |
Dex Liquidating Co.
 Dex Liquidating Co. Medical SpecialtiesHealth Technology Dextera Surgical, Inc. designs and manufactures proprietary stapling and anastomotic devices for cardiac and laparoscopic surgical procedures. It specializes in robotic-assisted surgery and medical devices. The company was founded by Bernard A. Hausen and Stephen A. Yencho on October 15, 1997 and is headquartered in Pleasanton, CA. | Health Technology |
Orquest, Inc.
 Orquest, Inc. Medical SpecialtiesHealth Technology Orquest, Inc. developed and manufactured bone graft materials. Its technology HEALOS Bone Graft Material, was designed and developed to reduce the time and pain associated with standard bone graft harvesting. Orquest was located in Mountain View, CA. | Health Technology |
| North American Instrument Corp. | Miscellaneous |
Devices for Vascular Intervention, Inc.
 Devices for Vascular Intervention, Inc. Miscellaneous Commercial ServicesCommercial Services Devices for Vascular Intervention, Inc. operated as a developer of catheters for coronary atherectomy. The company was founded by Simpson B. John and was headquartered in Santa Clara, CA. | Commercial Services |
QT Vascular Ltd.
 QT Vascular Ltd. Medical SpecialtiesHealth Technology QT Vascular Ltd. engages in the development, manufacture, and distribution of therapeutic solutions for the treatment of vascular diseases. Its products include Chocolate PTA Balloon Catheter, Chocolate Touch PTA Balloon Catheter, GliderfleX PTA Balloon Catheter, and GliderXtreme PTA Balloon Catheter. The company was founded by Eitan Konstantino in 2005 and is headquartered in Singapore. | Health Technology |
Colospan Ltd.
Colospan Ltd. Medical SpecialtiesHealth Technology Colospan Ltd. operates as a clinical stage and medical device company that develops a technology for colorectal surgery to prevent the profound clinical and economic pains associated with colorectal anastomotic leaks and diverting stomas. The company was founded by Boaz Assaf in December 2010 and is headquartered in Kfar Saba, Israel. | Health Technology |
Yor Labs, Inc.
Yor Labs, Inc. Medical SpecialtiesHealth Technology Yor Labs, Inc. offers an ultraportable-handheld device for diagnostic care. The company is headquartered in Portland, OR. | Health Technology |
Tulavi Therapeutics, Inc.
Tulavi Therapeutics, Inc. BiotechnologyHealth Technology Tulavi Therapeutics, Inc. develops therapeutics to treat neurally mediated diseases. It helps to treat aberrant neural reflex arcs in peripheral and visceral diseases. The company was founded was founded by Corinne Bright, Fred Khosravi and Henry Chen and is headquartered in Mountain View, CA. | Health Technology |
KL Acquisition Corp.
 KL Acquisition Corp. Financial ConglomeratesFinance KL Acquisition Corp. operates as a development stage company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on August 26, 2020 and is headquartered in New York, NY. | Finance |
| Cytokind, Inc. |
